Aminopterin LLC
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4
Ending by 2030
Nov 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 27, 2027The maintenance fee for Stable solid dosage forms of aminopterin (US 9,168,256) comes due Apr 27, 2027. Unpaid by Oct 27, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 4 of 4
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,129,383 | Aminopterin dosage forms and methods for inflammatory disorders In force · From the USPTO record | In force | From the USPTO record | |
| US 7,235,660 | Facile process for the preparation of high-purity aminopterin In force · From the USPTO record | In force | From the USPTO record | |
| US 9,168,256 | Stable solid dosage forms of aminopterin In force · From the USPTO record | In force | From the USPTO record | |
| US 8,349,837 | Pharmaceutical composition comprising racemic aminopterin In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 4: 1 lapsed for an unpaid fee · 2 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
Every application published under this name has become a patent.